Rabin Medical Center Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01732250
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

dafna yahav | GALIA AVRAHAMI | Institution of Hematology, Rabin Medical Center | Mical Paul | moshe yeshurun | ori snapiri | Yariv yogev